Vaccine against cancer diseases that are associated with the her-2/neu oncogene
EP1844788A1
HER-2/neu multi-peptide vaccine
CA2530655A1
Passive immune therapy against malignant melanoma
IL162857D0
Oral vaccination
DE10259053A1
Oral vaccine for vaccination against e.g. cancer comprises combination of antigen, especially tumor antigen, and gastric acidity reducing agent, e.g. antacid, H2-antagonist or proton pump inhibitor
EP1327450A1
Oral vaccination with naked tumor-antigen-mimotopes
EP1287831A1
Antigen mimotopes and vaccine against cancerous diseases
WO0178766A1
Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells
EP1236740A1
Vaccine against HER-2/neu oncogene-associated cancers
DE10105509A1
New ice-lollipop for treating oral mucositis comprises herbal extracts to give additional therapeutic effects
DE10041342A1
Preparing vaccine against cancer, useful for treatment or prevention, comprises coupling antibody mimetopes,selected from a phage-display library, to macromolecular carrier
DE10018403A1
Preparing vaccine against cancer, useful for treatment or prevention, comprises coupling antibody mimetopes,selected from a phage-display library, to macromolecular carrier
